MDMA-Assisted Therapy for PTSD: Clinical and Contemplative Aspects, by Jim Hopper, PhD
35-minute presentation by Dr. Jim Hopper, therapist for the FDA-approved phase 3 trial of MDMA-Assisted Therapy for PTSD. Delivered May 1, 2020 for a conference hosted by the Cambridge Health Alliance and Harvard Medical School, "Meditation and Psychotherapy: Learning from Non-Ordinary States."
Пікірлер